UNCY - Unicycive Therapeutics, Inc. News

Discover

UNCY

Unicycive Therapeutics, Inc.

5.28

2 x 3.76

2 x 5.73

bid

ask

0.59

12.58%

2 @ 04:00 PM

5.28 +0.00 (0.00%)

Ytd	-8.49%
1y	13.79%

4.45

day range

5.30

3.71

52 week range

8.74

Open	4.57	Prev Close	4.69	Low	4.45	High	5.30	Mkt Cap	144.64M
Vol	6.02M	Avg Vol	1.30M	EPS	-2.25	P/E	N/A	Forward P/E	-3.31
Beta	2.29	Short Ratio	0.74	Inst. Own	38.24%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	05-14	50-d Avg	7.47	200-d Avg	6.26	1yr Est	5.50

UNCY News

businesswire.com

UNICYCIVE THERAPEUTICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potent

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims aga

benzinga.com

Benchmark Maintains Speculative Buy on Unicycive Therapeutics, Lowers Price Target to $13

Benchmark analyst Bruce Jackson maintains Unicycive Therapeutics (NASDAQ:UNCY) with a Speculative

globenewswire.com

UNCY ALERT: Unicycive Therapeutics, Inc. Investigated for Securities Fraud by Block & Leviton; Inves

Block & Leviton is investigating Unicycive Therapeutics, Inc. (Nasdaq: $UNCY) for possible securitie

benzinga.com

Noble Capital Markets Maintains Outperform on Unicycive Therapeutics, Lowers Price Target to $50

Noble Capital Markets analyst Robert LeBoyer maintains Unicycive Therapeutics (NASDAQ:UNCY) with

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m

benzinga.com

HC Wainwright & Co. Maintains Buy on Unicycive Therapeutics, Lowers Price Target to $15

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Unicycive Therapeutics (NASDAQ:U

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#

benzinga.com

B. Riley Securities Maintains Buy on Unicycive Therapeutics, Maintains $22 Price Target

B. Riley Securities analyst Mayank Mamtani maintains Unicycive Therapeutics (NASDAQ:UNCY) with a

globenewswire.com

Johnson Fistel Investigates Unicycive Therapeutics, Inc. (NASDAQ: UNCY) on Behalf of Investors

SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Unicycive Therape

benzinga.com

Nasdaq Gains Over 300 Points; Chicago PMI Falls In June

US stocks traded higher, Nasdaq up 150 points. Dow up 0.02%, Nasdaq up 0.68%, S&P 500 up 0.28%.

benzinga.com

Why Is Unicycive Therapeutics Stock Falling Tuesday?

Unicycive Therapeutics ($UNCY) stock crashes over 46% as FDA rejects kidney disease drug NDA again o

benzinga.com

US Stocks Mixed; Home Prices Increase 1.1% In April

US stocks mixed, Dow falls 0.2%. Leading sectors: tech up 1%, real estate down 1.4%. S&P 500 up

benzinga.com

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market s

benzinga.com

Unicycive Therapeutics Receives FDA Complete Response Letter On Its Application For Oxylanthanum Car

Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therap

globenewswire.com

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum

-- Complete Response Letter relates to deficiencies previously identified at third-party manufacturi

benzinga.com

Unicycive Therapeutics Files Base Prospectus For Offering Up To $150M Securities

https://www.sec.gov/Archives/edgar/data/1766140/000121390026065819/ea0291789-s3_unicycive.htm

benzinga.com

Benchmark Maintains Speculative Buy on Unicycive Therapeutics, Raises Price Target to $18

Benchmark analyst Bruce Jackson maintains Unicycive Therapeutics (NASDAQ:UNCY) with a Speculative